StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Genocea Biosciences has a one year low of $0.00 and a one year high of $0.00. The company has […]